ABSTRACT Objective: Because serum calcitonin (CT) is a reliable marker of the presence, volume, and extent of disease in medullary thyroid cancer (MTC), both the ATA and NCCN guidelines use the 2-3 month post-operative CT value as the primary response to therapy variable that determines the type and int...
Biomarcadores de Tumor/sangre,
Calcitonina/sangre,
Carcinoma Neuroendocrino/sangre,
Carcinoma Neuroendocrino/cirugía,
Estudios de Seguimiento,
Periodo Posoperatorio,
Estudios Retrospectivos,
Neoplasias de la Tiroides/sangre,
Neoplasias de la Tiroides/cirugía,
Tiroidectomía,
Factores de Tiempo
Abstract Objective: To disclose the relationships between the anatomic features of cardiac myxomas and plasma interleukin (IL)-6 levels. Methods: Twelve patients undergoing cardiac myxoma resection at The First Hospital of Putian, Teaching Hospital, Fujian Medical University were enrolled into this stu...
Biomarcadores de Tumor/sangre,
Proteína C-Reactiva/análisis,
Ensayo de Inmunoadsorción Enzimática,
Neoplasias Cardíacas/sangre,
Neoplasias Cardíacas/patología,
Neoplasias Cardíacas/cirugía,
Interleucina-6/sangre,
Mixoma/sangre,
Mixoma/patología,
Mixoma/cirugía,
Periodo Posoperatorio,
Periodo Preoperatorio,
Valores de Referencia,
Estudios Retrospectivos,
Carga Tumoral
PTEN is the most commonly inactivated tumor suppressor gene in primary prostate cancer (PCa) and its loss is associated with poor clinical outcomes. ERG rearrangement is a genomic alteration frequently found in PCa and its prognostic significance has yielded mixed results. Although the association of PTE...
Biomarcadores de Tumor/sangre,
Biomarcadores de Tumor/genética,
Biomarcadores de Tumor/metabolismo,
Estudios de Cohortes,
Regulación Neoplásica de la Expresión Génica,
Inmunohistoquímica,
Clasificación del Tumor,
Fosfohidrolasa PTEN/sangre,
Fosfohidrolasa PTEN/genética,
Fosfohidrolasa PTEN/metabolismo,
Prevalencia,
Pronóstico,
Neoplasias de la Próstata/metabolismo,
Neoplasias de la Próstata/patología,
Neoplasias de la Próstata/cirugía,
Estudios Retrospectivos,
Regulador Transcripcional ERG/sangre,
Regulador Transcripcional ERG/genética,
Regulador Transcripcional ERG/metabolismo
Abstract Purpose: To investigate the prognostic value of 17 platelet-based prognostic scores in patients with malignant hepatic tumors after TACE therapy. Methods: In total, 92 patients were divided into death group and survival group according to long-term follow-up results. The AUC was calculated to ...
Aspartato Aminotransferasas/sangre,
Biomarcadores de Tumor/sangre,
Plaquetas/química,
Carcinoma Hepatocelular/sangre,
Carcinoma Hepatocelular/mortalidad,
Carcinoma Hepatocelular/terapia,
Quimioembolización Terapéutica/métodos,
Estimación de Kaplan-Meier,
Neoplasias Hepáticas/sangre,
Neoplasias Hepáticas/mortalidad,
Neoplasias Hepáticas/terapia,
Recuento de Plaquetas,
Pronóstico,
Curva ROC,
Estudios Retrospectivos
ABSTRACT Background: Metastasis is common in the diagnosis of pancreatic cancer, and the presence of epithelial-mesenchymal transition markers in circulating tumor cells may suggest worse prognosis. Aim: To correlate the number of circulating tumor cells (CTCs) in the peripheral blood of patients with...
Adenocarcinoma/sangre,
Adenocarcinoma/patología,
Biomarcadores de Tumor/sangre,
Progresión de la Enfermedad,
Transición Epitelial-Mesenquimal,
Estimación de Kaplan-Meier,
Metaloproteinasa 2 de la Matriz/sangre,
Clasificación del Tumor,
Estadificación de Neoplasias,
Células Neoplásicas Circulantes/química,
Células Neoplásicas Circulantes/patología,
Neoplasias Pancreáticas/sangre,
Neoplasias Pancreáticas/patología,
Estudios Prospectivos,
Receptor Tipo I de Factor de Crecimiento Transformador beta/sangre,
Valores de Referencia,
Factores de Tiempo,
Carga Tumoral,
Vimentina/sangre
ABSTRACT Purpose: The present study evaluates chondroitin sulfate (CS) and heparan sulfate (HS) in the urine and hyaluronic acid (HA) in the plasma of patients with prostate cancer before and after treatment compared to a control group. Materials and Methods: Plasma samples were used for HA dosage and ...
Background: Conventional serum tumor markers (CSTM) are widely used for monitoring patients with cancer. However, their usefulness as a diagnostic tool is controversial in primary or metastatic liver cancer (PMLC). Aim: To evaluate the diagnostic performance of the most commonly requested CSTM in the di...
Biomarcadores de Tumor/sangre,
Neoplasias Hepáticas/sangre,
Neoplasias Hepáticas/diagnóstico,
Antígeno Ca-125/sangre,
Antígeno CA-19-9/sangre,
Antígeno Carcinoembrionario/sangre,
Metástasis de la Neoplasia/diagnóstico,
Valor Predictivo de las Pruebas,
Antígeno Prostático Específico,
Curva ROC,
Estudios Retrospectivos,
alfa-Fetoproteínas/análisis
ABSTRACT BACKGROUND: Gastric adenocarcinoma is the fourth most common cause of cancer-associated death worldwide. OBJECTIVE: We evaluated the immunological status of patients with gastric cancer before surgery and circulating cytokines as potential diagnostic biomarkers for gastric cancer. METHODS: ...
Adenocarcinoma/sangre,
Adenocarcinoma/diagnóstico,
Biomarcadores de Tumor/sangre,
Estudios de Casos y Controles,
Ensayo de Inmunoadsorción Enzimática,
Interleucina-10/sangre,
Interleucina-12/sangre,
Interleucina-2/sangre,
Persona de Mediana Edad,
Neoplasias Gástricas/sangre,
Neoplasias Gástricas/diagnóstico
ABSTRACT Purpose: To investigate the prognostic role of preoperative albumin/globulin ratio (AGR) in predicting disease-free survival (DFS) and overall survival (OS) in localized and locally advanced clear cell renal cell carcinoma (RCC) patients. Patients and Methods: 162 patients who met the criteria...
Biomarcadores de Tumor/sangre,
Carcinoma de Células Renales,
Carcinoma de Células Renales/mortalidad,
Carcinoma de Células Renales/cirugía,
Supervivencia sin Enfermedad,
Globulinas/análisis,
Neoplasias Renales/sangre,
Neoplasias Renales/mortalidad,
Neoplasias Renales/cirugía,
Persona de Mediana Edad,
Valor Predictivo de las Pruebas,
Pronóstico,
Estudios Retrospectivos,
Sensibilidad y Especificidad,
Albúmina Sérica/análisis
ABSTRACT Purposes: The aim of this study was to determine the diagnostic significance of fibronectin type III domain containing protein 5 (FNDC5)/Irisin levels in the sera of patients with renal cell cancer. Materials and Methods: In the study, 48 individuals were evaluated. The patient group included ...
Biomarcadores de Tumor/sangre,
Antígeno Carcinoembrionario/sangre,
Carcinoma de Células Renales/sangre,
Carcinoma de Células Renales/diagnóstico,
Carcinoma de Células Renales/patología,
Estudios de Casos y Controles,
Ensayo de Inmunoadsorción Enzimática,
Fibronectinas/sangre,
Neoplasias Renales/sangre,
Neoplasias Renales/diagnóstico,
Neoplasias Renales/patología,
Persona de Mediana Edad,
Clasificación del Tumor,
Estadificación de Neoplasias,
Valores de Referencia,
Reproducibilidad de los Resultados,
Estudios Retrospectivos,
Sensibilidad y Especificidad,
Estadísticas no Paramétricas
